|
![]() |
|
|
Secobarbital: profile and news
The perils of self-prescription May 5, 2006 Other information Indication For the Short-term treatment of intractable insomnia for patients habituated to barbiturates Pharmacology Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation. Mechanism Of Action Secobarbital binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. Drug Category Hypnotics and Sedatives; Adjuvants; Barbiturates; ATC:N05CA06 Brand Names/Synonyms Seconal (TN); Secobarbital (USP); Novosecobarb; Barbosec; Bipanal; Bipinal sodium; CHEMBANK2949; DEA No. 2315; DEA No. 2316; Evronal; Evronal Sodium; Evrronal; HSDB 3182; Hypotrol; Hyptran; Imesonal; Immenoctal; Immenox; Meballymal; Meballymal sodium; Meballymalum; Pramil; Quinalbarbital; Quinalbarbitone; Quinalbarbitone sodium; Quinalspan; Sebar; Seco 8; Secobarbital; Secobarbital Sodium; Secobarbital [USAN:INN]; Secobarbital suppository dosage form; Secobarbitale [DCIT]; Secobarbitalum [INN-Latin]; Secobarbitone; Seconal; Seconal Sodium; Sedutain; Seotal; Sodium Secobarbital; Sodium Seconal; Sodium quinalbarbitone; Somosal; Synate; Trisomnin; (+/-)-Secobarbital; EINECS 200-982-2; Secobarbital (USP); Seconal (TN) Dosage Forms CAPSULE Absorption Not Available Interactions Interations Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers. Chemical IUPAC Name 5-(1-methylbutyl)-5-prop-2-enyl-hexahydropyrimidine-2,4,6-trione Chemical Formula C12H18N2O3 Half Life Not Available Drug Type Approved Drug # Accession No APRD00497 CAS Registry Number 76-73-3 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |